Biological treatment in adult-onset Still's disease

Best Practice and Research: Clinical Rheumatology

Volumn 26, Issue 4, 2012, Pages 477-487

  Pouchot, Jacques ^a   Arlet, Jean Benoît ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Adult onset Still's disease; Anti IL 1; Anti IL 6; Anti TNF ; Biological agents; Canakinumab

Indexed keywords

ABATACEPT; ADALIMUMAB; AZATHIOPRINE; CANAKINUMAB; CYCLOPHOSPHAMIDE; ETANERCEPT; GAMMA INTERFERON; IMMUNOGLOBULIN; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 6; LEFLUNOMIDE; METHOTREXATE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RILONACEPT; TOCILIZUMAB; TUMOR NECROSIS FACTOR ALPHA;

ADULT ONSET STILL DISEASE; ADULT RESPIRATORY DISTRESS SYNDROME; ARTHRALGIA; ARTHRITIS; ARTICLE; DRUG DOSE INCREASE; FEVER; HUMAN; INJECTION SITE ERYTHEMA; JUVENILE RHEUMATOID ARTHRITIS; MACROPHAGE; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; SINGLE DRUG DOSE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T LYMPHOCYTE;

EID: 84867355837     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2012.07.002     Document Type: Review

References (100)

1. E.G. Bywaters Still's disease in the adult Annals of the Rheumatic Diseases 30 1971 121 133
2. M. Yamaguchi, A. Ohta, and T. Tsunematsu Preliminary criteria for classification of adult Still's disease The Journal of Rheumatology 19 1992 424 430
3. J. Pouchot, J.S. Sampalis, and F. Beaudet Adult Still's disease: manifestations, disease course, and outcome in 62 patients Medicine (Baltimore) 70 1991 118 136
4. B. Fautrel Adult-onset Still disease Best Practice Research and Clinical Rheumatology 22 2008 773 792
5. K. Wakai, A. Ohta, and A. Tamakoshi Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan Journal of Epidemiology 7 1997 221 225
6. L.B. van de Putte, and J.M. Wouters Adult-onset Still's disease Bailliere's Clinical Rheumatology 5 1991 263 275
7. G. Magadur-Joly, E. Billaud, and J.H. Barrier Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France Annals of the Rheumatic Diseases 54 1995 587 590
8. J. Pouchot How can we improve the management of adult-onset Still's disease? Joint Bone Spine 74 2007 117 119
9. S. Franchini, L. Dagna, and F. Salvo Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease Arthritis and Rheumatism 62 2010 2530 2535
10. B. Fautrel, C. Borget, and S. Rozenberg Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease The Journal of Rheumatology 26 1999 373 378
11. P. Efthimiou, A. Kontzias, C.M. Ward, and N.S. Ogden Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy? Nature Clinical Practice Rheumatology 3 2007 328 335
12. J.B. Arlet, D.B. Le Thi Huong, J. Pouchot, and J.C. Piette Current concepts on the physiopathology of adult-onset Still's disease Revue de Médecine Interne 26 2005 549 556
13. T. Hoshino, A. Ohta, and D. Yang Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still's disease The Journal of Rheumatology 25 1998 396 398
14. T. Fujii, T. Nojima, and H. Yasuoka Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease Rheumatology (Oxford) 40 2001 1398 1404
15. Y. Kawaguchi, H. Terajima, and M. Harigai Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease Arthritis and Rheumatism 44 2001 1716 1717
16. M. Kawashima, M. Yamamura, and M. Taniai Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease Arthritis and Rheumatism 44 2001 550 560
17. D.Y. Chen, J.L. Lan, F.J. Lin, and T.Y. Hsieh Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease The Journal of Rheumatology 31 2004 2189 2198
18. J.H. Choi, C.H. Suh, and Y.M. Lee Serum cytokine profiles in patients with adult onset Still's disease The Journal of Rheumatology 30 2003 2422 2427
19. F. Martinon, A. Mayor, and J. Tschopp The inflammasomes: guardians of the body Annual Review of Immunology 27 2009 229 265
20. F. Hayem Is Still's disease an autoinflammatory syndrome? Joint Bone Spine 76 2009 7 9
21. C. Stambe, and I.P. Wicks Tnfalpha and response of treatment-resistant adult-onset Still's disease to thalidomide Lancet 352 1998 544 545
22. H.G. Kraetsch, C. Antoni, J.R. Kalden, and B. Manger Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences Annals of the Rheumatic Diseases 60 Suppl. 3 2001 iii55 iii57
23. L. Cavagna, R. Caporali, and O. Epis Infliximab in the treatment of adult Still's disease refractory to conventional therapy Clinical and Experimental Rheumatology 19 2001 329 332
24. A. Kokkinos, A. Iliopoulos, and P. Greka Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients Clinical Rheumatology 23 2004 45 49
25. P. Caramaschi, D. Biasi, A. Carletto, and L.M. Bambara A case of adult onset Still's disease treated with infliximab Clinical and Experimental Rheumatology 20 2002 113
26. I. Olivieri, G. de Stefano, and A. Padula Infliximab in a case of early adult-onset Still's disease Clinical Rheumatology 22 2003 369 370
27. B. Fautrel, J. Sibilia, X. Mariette, and B. Combe Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases Annals of the Rheumatic Diseases 64 2005 262 266
28. M. Michel, C. Duvoux, C. Hezode, and D. Cherqui Fulminant hepatitis after infliximab in a patient with hepatitis b virus treated for an adult onset Still's disease The Journal of Rheumatology 30 2003 1624 1625
29. M.E. Husni, A.L. Maier, and P.J. Mease Etanercept in the treatment of adult patients with Still's disease Arthritis and Rheumatism 46 2002 1171 1176
30. D.T. Felson, J.J. Anderson, and M. Boers American college of rheumatology preliminary definition of improvement in rheumatoid arthritis Arthritis and Rheumatism 38 1995 727 735
31. R.A. Asherson, and L. Pascoe Adult onset Still's disease: response to Enbrel Annals of the Rheumatic Diseases 61 2002 859 860 author reply 60
32. R. Kumari, and S.S. Uppal Prolonged remission in adult-onset Still's disease with etanercept Clinical Rheumatology 25 2006 106 108
33. J. Serratrice, B. Granel, and P. Disdier Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still's disease The American Journal of Medicine 115 2003 589 590
34. E.S. Chung, M. Packer, and K.H. Lo Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-tnf therapy against congestive heart failure (ATTACH) trial Circulation 107 2003 3133 3140
35. D.L. Mann, J.J. McMurray, and M. Packer Targeted anticytokine therapy in patients with chronic heart failure: results of the randomized etanercept worldwide evaluation (RENEWAL) Circulation 109 2004 1594 1602
36. A. Kuek, A. Weerakoon, K. Ahmed, and A.J. Ostor Adult-onset Still's disease and myocarditis: successful treatment with intravenous immunoglobulin and maintenance of remission with etanercept Rheumatology (Oxford) 46 2007 1043 1044
37. D.H. Yang, D.M. Chang, and J.H. Lai Etanercept as a rescue agent in patient with adult onset Still's disease complicated with congestive heart failure Rheumatology International 29 2008 95 98
38. S. Pay, N. Turkcapar, and M. Kalyoncu A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis Clinical Rheumatology 25 2006 639 644
39. D.J. Lovell, E.H. Giannini, and A. Reiff Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric rheumatology collaborative study group The New England Journal of Medicine 342 2000 763 769
40. S. Agarwal, J. Moodley, and G. Ajani Goel A rare trigger for macrophage activation syndrome Rheumatology International 31 2011 405 407
41. M. Benucci, G.F. Li, A. Del Rosso, and M. Manfredi Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: the first case report Clinical and Experimental Rheumatology 23 2005 733
42. C. Dechant, P. Schauenberg, and C.E. Antoni Longterm outcome of TNF blockade in adult-onset Still's disease Dtsch Med Wochenschr 129 2004 1308 1312
43. B.M. Mehta, P.J. Hashkes, R. Avery, and C.L. Deal A 21-year-old man with Still's disease with fever, rash, and pancytopenia Arthritis Care and Research (Hoboken) 62 2010 575 579
44. N.E. Aikawa, A.C. Ribeiro, and C.G. Saad Is anti-TNF switching in refractory Still's disease safe and effective? Clinical Rheumatology 30 2011 1129 1134
45. A.A. Fitzgerald, S.A. Leclercq, and A. Yan Rapid responses to anakinra in patients with refractory adult-onset Still's disease Arthritis and Rheumatism 52 2005 1794 1803
46. D. Aeberli, S. Oertle, and H. Mauron Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders Swiss Medical Weekly 132 2002 414 422
47. C.T. Berger, M. Recher, U. Steiner, and T.M. Hauser A patient's wish: anakinra in pregnancy Annals of the Rheumatic Diseases 68 2009 1794 1795
48. G.D. Kalliolias, P.E. Georgiou, and I.A. Antonopoulos Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial Annals of the Rheumatic Diseases 66 2007 842 843
49. I. Kotter, A. Wacker, and S. Koch Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature Seminars in Arthritis and Rheumatism 37 2007 189 197
50. L. Naumann, E. Feist, and A. Natusch IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease Annals of the Rheumatic Diseases 69 2010 466 467
51. J. Rech, M. Ronneberger, and M. Englbrecht Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade Annals of the Rheumatic Diseases 70 2011 390 392
52. X. Puechal, M. DeBandt, and J.M. Berthelot Tocilizumab in refractory adult Still's disease Arthritis Care and Research (Hoboken) 63 2011 155 159
53. K.S. Leslie, H.J. Lachmann, and E. Bruning Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1/NALP3 mutations Archives of Dermatology 142 2006 1591 1597
54. S. Debiais, F. Maillot, and L. Luca Efficacy of anakinra in a case of refractory Still disease Journal of Clinical Rheumatology 14 2008 357 358
55. F.M. Vasques Godinho, M.J. Parreira Santos, and J. Canas da Silva Refractory adult onset Still's disease successfully treated with anakinra Annals of the Rheumatic Diseases 64 2005 647 648
56. K. El Karoui, A. Karras, and G. Lebrun Thrombotic microangiopathy and Purtscher-like retinopathy associated with adult-onset Still's disease: a role for glomerular vascular endothelial growth factor? Arthritis and Rheumatism 61 2009 1609 1613
57. T. Lequerre, P. Quartier, and D. Rosellini Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France Annals of the Rheumatic Diseases 67 2008 302 308
58. M. Gattorno, A. Piccini, and D. Lasiglie The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis Arthritis and Rheumatism 58 2008 1505 1515
59. P. Quartier, F. Allantaz, and R. Cimaz A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial) Annals of the Rheumatic Diseases 70 2011 747 754
60. P.A. Nigrovic, M. Mannion, and F.H. Prince Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series Arthritis and Rheumatism 63 2011 545 555
61. S. Guignard, G. Dien, and M. Dougados Severe systemic inflammatory response syndrome in a patient with adult onset Still's disease treated with the anti-IL1 drug anakinra: a case report Clinical and Experimental Rheumatology 25 2007 758 759
62. H. Tamaki, H. Shimizu, and E. Hiraoka Marked effect and steroid-sparing ability of anakinra on a patient with refractory adult-onset Still's disease Modern Rheumatology 20 2010 200 204
63. J. Maier, G. Birkenfeld, and J. Pfirstinger Effective treatment of steroid refractory adult-onset Still's disease with anakinra The Journal of Rheumatology 35 2008 939 941
64. M. Lahiri, and G.G. Teng A case of refractory adult-onset Still's disease treated with anakinra International Journal of Rheumatic Diseases 13 2010 e36 e41
65. H.J. Lachmann, I. Kone-Paut, and J.B. Kuemmerle-Deschner Use of canakinumab in the cryopyrin-associated periodic syndrome The New England Journal of Medicine 360 2009 2416 2425
66. Kontzias A, Efthimiou P. The use of canakinumab, a novel IL-1beta long-acting inhibitor, in refractory adult-onset Still's disease. Seminars in Arthritis and Rheumatism: in press.
67. N. Ruperto, P. Quartier, and N. Wulffraat A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features Arthritis and Rheumatism 64 2012 557 567
68. Petryna O, Cush JJ, Efthimiou P. IL-1 trap rilonacept in refractory adult onset Still's disease. Annals of the Rheumatic Diseases: in press.
69. P. Efthimiou, and S. Georgy Pathogenesis and management of adult-onset Still's disease Seminars in Arthritis and Rheumatism 36 2006 144 152
70. M. Iwamoto, H. Nara, and D. Hirata Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease Arthritis and Rheumatism 46 2002 3388 3389
71. K. Matsumoto, T. Nagashima, and S. Takatori Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab Clinical Rheumatology 28 2009 485 487
72. M. De Bandt, and B. Saint-Marcoux Tocilizumab for multirefractory adult-onset Still's disease Annals of the Rheumatic Diseases 68 2009 153 154
73. Naniwa T, Ito R, Watanabe M, et al. Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still's disease. Clinical Rheumatology: in press.
74. K. Sumida, Y. Ubara, and J. Hoshino Etanercept-refractory adult-onset Still's disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab Clinical Rheumatology 29 2010 1191 1194
75. R. Thonhofer, M. Hiller, and H. Just Treatment of refractory adult-onset Still's disease with tocilizumab: report of two cases and review of the literature Rheumatology International 31 2011 1653 1656
76. H. Nakahara, T. Mima, and N. Yoshio-Hoshino A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years Modern Rheumatology 19 2009 69 72
77. M. Yoshimura, J. Makiyama, and T. Koga Successful treatment with tocilizumab in a patient with refractory adult-onset Still's disease (AOSD) Clinical and Experimental Rheumatology 28 2010 141 142
78. K. Perdan-Pirkmajer, S. Praprotnik, and M. Tomsic A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature Clinical Rheumatology 29 2010 1465 1467
79. D. Kishida, Y. Okuda, and M. Onishi Successful tocilizumab treatment in a patient with adult-onset Still's disease complicated by chronic active hepatitis B and amyloid A amyloidosis Modern Rheumatology 21 2011 215 218
80. M. Kobayashi, Y. Takahashi, and H. Yamashita Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome Modern Rheumatology 21 2011 92 96
81. G.R. Sabnis, Y.A. Gokhale, and U.P. Kulkarni Tocilizumab in refractory adult-onset Still's disease with aseptic meningitis - efficacy of interleukin-6 blockade and review of the literature Seminars in Arthritis and Rheumatism 40 2011 365 368
82. Y. Sekkach, M. Elqatni, and A.E. Khattabi Antagonists of interleukin-6 (tocilizumab), in adult refractory Still disease La Presse Médicale 40 2011 e333 e337
83. Y. Yoshida, M. Sakamoto, and K. Yokota Tocilizumab improved both clinical and laboratory manifestations except for interleukin-18 in a case of multiple drug-resistant adult-onset Still's disease Internal Medicine 50 2011 1757 1760
84. R. Sakai, H. Nagasawa, and E. Nishi Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review Clinical Rheumatology 31 2012 569 574
85. Suematsu R, Ohta A, Matsuura E, et al. Therapeutic response of patients with adult Still's disease to biologic agents: multicenter results in Japan. Modern Rheumatology: in press.
86. S. Yokota, T. Imagawa, and M. Mori Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial Lancet 371 2008 998 1006
87. S. Permal, B. Wechsler, and J. Cabane Treatment of Still disease in adults with intravenous immunoglobulins Revue de Médecine Interne 16 1995 250 254
88. S. Vignes, B. Wechsler, and Z. Amoura Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal anti-inflammatory drugs Clinical and Experimental Rheumatology 16 1998 295 298
89. A.N. Bennett, P. Peterson, and S. Sangle Adult onset Still's disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil Rheumatology (Oxford) 43 2004 795 799
90. S. De Vita, G.F. Ferraccioli, and E. Di Poi High dose intravenous immunoglobulin therapy for rheumatic diseases: clinical relevance and personal experience Clinical and Experimental Rheumatology 14 Suppl. 15 1996 S85 S92
91. J.R. Diamond Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura (HUS/TTP) complicating adult Still's disease: remission induced with intravenous immunoglobulin g Journal of Nephrology 10 1997 253 257
92. A. Ohta, M. Yamaguchi, and T. Tsunematsu Adult Still's disease: a multicenter survey of Japanese patients The Journal of Rheumatology 17 1990 1058 1063
93. T. Mahmud, and G.R. Hughes Intravenous immunoglobulin in the treatment of refractory adult Still's disease The Journal of Rheumatology 26 1999 2067 2068
94. E. Liozon, K. Ly, Y. Aubard, and E. Vidal Intravenous immunoglobulins for adult Still's disease and pregnancy Rheumatology (Oxford) 38 1999 1024 1025
95. R. Kulke, M. Koeppel, and D. Hey Treatment of adult Still's disease with intravenous immunoglobulin Lancet 347 1996 337
96. A.M. Prieur Intravenous immunoglobulins in Still's disease: still controversial, still unproven The Journal of Rheumatology 23 1996 797 800
97. R.A. Ostrowski, R. Tehrani, and R. Kadanoff Refractory adult-onset still disease successfully treated with abatacept Journal of Clinical Rheumatology 17 2011 315 317
98. L. Quartuccio, M. Maset, and S. De Vita Efficacy of abatacept in a refractory case of adult-onset Still's disease Clinical and Experimental Rheumatology 28 2010 265 267
99. C. Masson, X. Le Loet, and F. Liote Adult Still's disease. Part II. Management, outcome, and prognostic factors Revue du Rhumatisme (English Edition) 62 1995 758 765
100. G. Moulis, L. Sailler, and L. Astudillo May anakinra be used earlier in adult onset Still disease? Clinical Rheumatology 29 2010 1199 1200